Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | FCER2 | P06734 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 2/20 | 0.37 |
| ▸ | FNTB | P49356 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CPA3 | P15088 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6048015 | 1.00 | KDM4E (0.38) | KDM4EALDH1A1MAPTFCER2FNTA | |
| SCHEMBL4560596 | 0.74 | MME (0.42) | KDM4EALDH1A1MAPTFNTAFNTB | |
| SCHEMBL4560594 | 0.74 | MME (0.42) | KDM4EALDH1A1MAPTFNTAFNTB | |
| SCHEMBL24945572 | 0.71 | CTRB1 (0.55) | ALDH1A1 | |
| SCHEMBL2929213 | 0.71 | FCER2 (0.44) | FCER2CPA3FOLH1 | |
| SCHEMBL24945573 | 0.71 | CTRB1 (0.55) | ALDH1A1 | |
| SCHEMBL19033477 | 0.71 | MMP9 (0.44) | — | |
| SCHEMBL8558698 | 0.70 | NAALAD2 (0.51) | ALDH1A1FFAR1CPA3FOLH1 | |
| SCHEMBL24817200 | 0.69 | — | — | |
| SCHEMBL158241 | 0.66 | SIRT1 (0.42) | ALDH1A1MAPTCYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2204383-B1 | Processes for preparing eptifibatide and pertinent intermediate compounds | MILLENNIUM PHARM INC (US) | 2011-08-10 | — | — | EP | disclosed |
| EP-2204383-A1 | Processes for preparing eptifibatide and pertinent intermediate compounds | Millennium Pharmaceuticals, Inc. (US) | 2010-07-07 | — | — | EP | disclosed |
| US-20100105609-A1 | Processes for Preparing Eptifibatide | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| US-7674768-B2 | Processes for preparing eptifibatide | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-03-09 | — | — | US | disclosed |
| EP-1735345-B1 | PROCESSES FOR PREPARING EPTIFIBATIDE AND PERTINENT INTERMEDIATE COMPOUNDS | MILLENNIUM PHARM INC (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-1735345-A2 | PROCESSES FOR PREPARING EPTIFIBATIDE AND PERTINENT INTERMEDIATE COMPOUNDS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2006-12-27 | — | — | EP | disclosed |
| US-20060036071-A1 | Processes for preparing eptifibatide | MILLENNIUM PHARMACEUTICALS, INC. | 2006-02-16 | — | — | US | disclosed |
| WO-2005100381-A2 | PROCESSES FOR PREPARING EPTIFIBATIDE AND PERTINENT INTERMEDIATE COMPOUNDS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105609-A1 | Processes for Preparing Eptifibatide | PTMS, VIP, ENPP2 | KDM4E 4463/4885ALDH1A1 2474/4885MAPT 4817/4885 |
| US-20060036071-A1 | Processes for preparing eptifibatide | PTMS, VIP, ENPP2 | KDM4E 4463/4885ALDH1A1 2474/4885MAPT 4817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.